Victory Capital Management
KPRX icon

Victory Capital Management’s Kiora Pharmaceuticals KPRX Stock Holding History

Victory Capital Management’s Portfolio KPRX Stock Details KPRX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2020
Q2 		– Sell
-4
Closed -$8K – 2896
2020
Q1 		$8K Buy
+4
New +$8.61K ﹤0.01% 3373
2019
Q4 		– Sell
-1
Closed -$1K – 2960
2019
Q3 		$1K Buy
+1
New +$1.15K ﹤0.01% 3703

Other funds holding KPRX

AC
Armistice Capital New York $5.62B AUM 36.06% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
US Bancorp
US Bancorp Minneapolis, Minnesota $82.4B AUM 19.69% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return
Royal Bank of Canada
Royal Bank of Canada Toronto, Ontario, Canada $570B AUM 27.57% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Osaic Holdings
Osaic Holdings Scottsdale, Arizona $68.3B AUM 20.5% 1-Year Est. Return

Victory Capital Management's KPRX Position: Q2 2020 in Review

Victory Capital Management sold out of Kiora Pharmaceuticals (KPRX) in Q2 2020, closing a stake of 4 shares — an estimated $8K sold.

Victory Capital Management first reported a position in KPRX in Q3 2019 and held it in 2 quarters. The position peaked at $8K in Q1 2020. 10 funds tracked by Wall St. Rank hold KPRX as of Q2 2020.

  • Victory Capital Management reported no remaining Kiora Pharmaceuticals position as of Q2 2020 after selling out during the quarter.
  • Victory Capital Management sold 4 Kiora Pharmaceuticals shares in Q2 2020, an estimated $8K.
  • Victory Capital Management first reported a position in Kiora Pharmaceuticals in Q3 2019 and held it in 2 quarters.
  • Victory Capital Management's Kiora Pharmaceuticals position peaked at $8K in Q1 2020.
  • 10 funds tracked by Wall St. Rank held Kiora Pharmaceuticals as of Q2 2020.

Based on Victory Capital Management's 13F filing for Q2 2020, filed 7 Aug 2020.